
Please try another search
Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company that develops differentiated and novel therapies to address the unmet medical needs of patients with cancer in the United States. Its VersAptx bioconjugation platform combines different targeting, linker, and payload technologies to develop antibody-drug conjugates (ADC) and small molecule drug conjugates (SMDC); and provides CellTrapper technology for use in reduction of payload cellular permeability. The company develops VIP943, an antibody drug conjugate in Phase 1 dose-escalation study for relapsed/refractory acute myeloid leukemia, higher-risk MDS, and B-cell acute lymphoblastic leukemia; VIP236, an SMDC, which is in Phase 1 dose-escalation study for the treatment of patients with advanced or metastatic solid tumors; and VIP924, an anti-CXCR5 ADC that leverages the same effector chemistry in preclinical studies for b-cell malignancies. It has a collaboration with the National Institutes of Health for the Phase 1 dose-escalation of enitociclib, a highly selective cyclin-dependent kinase 9 inhibitor. The company was formerly known as Vincera Pharma, Inc. and changed its name to Vincerx Pharma, Inc. in January 2021. Vincerx Pharma, Inc. was founded in 2019 and is headquartered in San Mateo, California.
Name | Age | Since | Title |
---|---|---|---|
Andre Goy | - | 2021 | Member of Scientific Advisory Board |
Raquel E. Izumi | 55 | 2020 | Co-Founder, Acting CEO, Secretary & Director |
Howard A. Burris | - | 2021 | Member of Scientific Advisory Board |
Anthony W. Tolcher | - | 2021 | Member of Scientific Advisory Board |
Naval G. Daver | - | 2024 | Member of Scientific Advisory Board |
Ian W. Flinn | - | 2021 | Member of Scientific Advisory Board |
Marina Konopleva | - | 2024 | Member of Scientific Advisory Board |
Uma Borate | - | 2024 | Member of Scientific Advisory Board |
Amer Zeidan | - | 2024 | Member of Scientific Advisory Board |
Alice Mims | - | 2024 | Member of Scientific Advisory Board |
Apostolia Tsimberidou | - | 2024 | Member of Scientific Advisory Board |
John C. Byrd | - | 2021 | Founder & Chairman of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review